Fmc Corp Stock Price, News & Analysis

FMC Corporation (NYSE: FMC) has announced its board of directors has declared a regular quarterly dividend of $0.58 per share. The dividend will be paid on October 16, 2025, to shareholders of record at the close of business on September 30, 2025.

FMC Corporation (NYSE: FMC) has received regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of its fluindapyr technology in the EMEA region. The approval covers applications for oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.

Tremisia® fungicide combines FMC's proprietary fluindapyr molecule with flutriafol, providing a dual mode of action that targets diseases including Alternaria and Sclerotinia in sunflower, and Septoria and rust in wheat. The product has already been successfully commercialized in Argentina, Brazil, Mexico, Paraguay, South Korea, and the United States, with conditional approval in the Philippines.

The company plans to expand the availability of fluindapyr-based products to Bolivia, Chile, Colombia, Honduras, and India, pending regulatory approvals.

FMC Corporation has scheduled its second quarter 2025 earnings release for Wednesday, July 30, 2025, after market close. The company will host a webcast conference call the following day, Thursday, July 31, 2025, at 9:00 a.m. ET. The call will be accessible to the public via internet broadcast and telephone, with both U.S. local and toll-free numbers provided. A replay of the call will be available from 11:00 a.m. ET on July 31 until August 7, 2025, through both internet and telephone access.

FMC Corporation has announced a strategic partnership with Corteva Agriscience to expand the reach of its fluindapyr fungicide technology in U.S. corn and soybean markets. The agreement allows both companies to market fluindapyr-based products, with FMC continuing to offer Adastrio fungicide while developing new products, and Corteva launching its own fluindapyr-based product in early 2026, pending EPA approval. The collaboration targets approximately 175 million planted acres across corn and soybean markets, offering farmers enhanced protection against diseases like tar spot and southern rust. Fluindapyr, a Group 7 fungicide, provides extended residual control and effectively manages pathogen resistance. FMC has already commercialized fluindapyr products in several countries including Argentina, Brazil, and South Korea, with planned launches in Chile, Honduras, India, and Ukraine pending regulatory approval.

FMC Corporation (NYSE: FMC) has released its 2024 sustainability report, showcasing significant progress in environmental initiatives and agricultural innovation. The company achieved a 27% reduction in Scope 1 and 2 greenhouse gas emissions from its 2021 baseline through energy efficiency projects and clean energy procurement. Additionally, waste reduction initiatives led to a 6% decrease in waste generation, with both environmental efforts contributing to $6 million in operating cost savings.

The report highlights FMC's R&D pipeline developments, including new fungicides, pheromone-based products, microbial solutions, and diamide formulations. The company's integrated approach focuses on helping farmers improve productivity while promoting sustainable agricultural practices such as reduced water usage, enhanced soil quality, and pollinator protection.

FMC Corporation reported Q1 2025 results with revenue of $791 million, down 14% from Q1 2024. The company posted a GAAP loss of $0.12 per share and adjusted earnings of $0.18 per share, down 50% year-over-year.

Despite Q1 challenges, FMC maintains its full-year 2025 outlook with:

• Revenue forecast: $4.15-4.35 billion
• Adjusted EBITDA: $870-950 million
• Adjusted EPS: $3.26-3.70

Regional performance varied significantly: North America sales declined 28%, Latin America grew 10%, Asia dropped 24%, and EMEA fell 11%. The company expects stronger second-half performance with a projected 7% increase in sales and 11% growth in adjusted EBITDA compared to 2024.

FMC Corporation (NYSE: FMC) has announced its latest quarterly dividend declaration. The company's board of directors has approved a regular quarterly dividend of 58 cents per share.

The dividend will be distributed on July 17, 2025, to shareholders who are on record at the close of business on June 30, 2025. This announcement demonstrates FMC's continued commitment to providing regular returns to its shareholders through dividend payments.

FMC Corporation has elected Steven Merkt to its Board of Directors, effective April 29, 2025. Merkt, who will serve on the Audit and Nominating and Corporate Governance Committees, brings over 30 years of experience in international manufacturing and operational excellence.

As former president of TE Connectivity's Transportation Solutions segment (2012-2024), Merkt led significant profitability growth and managed manufacturing operations across 20+ countries. His experience includes leadership roles as president of TE's global Automotive business in Germany and vice president of Asia Pacific Automotive operations in China.

Merkt previously served on the Board of Directors of Arcadium Lithium before its Rio Tinto acquisition and was a board member at Livent Corporation. Pierre Brondeau, FMC chairman and CEO, welcomed Merkt's appointment, citing his proven track record in driving growth and operational excellence as valuable assets for FMC's growth strategy in agricultural sciences.

FMC (NYSE: FMC) has announced the appointment of Sara Velazquez Ponessa as executive vice president, general counsel and corporate secretary, effective June 1, 2025. She will succeed Michael F. Reilly, who will retire on July 1, 2025, after 23 years with the company.

Reilly, who joined FMC in 2002, has served as executive vice president, general counsel and secretary since April 2019. Under his leadership, FMC transformed into a focused agricultural sciences company through various strategic initiatives, acquisitions, and divestitures.

Ponessa previously served as senior business counsel at FMC from 2012 to 2018, and later as general counsel at Livent , where she led the legal aspects of its 2018 IPO and 2019 spinoff from FMC. Most recently, she served as vice president, general counsel and secretary at Arcadium Lithium plc.